OpenAlex
PricingAboutJobs
Log inGet started
Work

Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder

HTML

Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Psychiatry
DOI: 10.4088/jcp.v60n0610
Authors: Marcio Versiani, Lembit Mehilane, Peter Gaszner, René Arnaud-Castiglioni, The Metrifonate Study Group
Institution: Universidade Federal do Rio de Janeiro
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: reboxetine, selective norepinephrine reuptake inhibitors, major depressive disorder, recurrent depression, relapse prevention, depression recurrence, long-term antidepressant treatment, antidepressant efficacy, tolerability, adverse events, medication adherence
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2072962598
FWCI: 6.762
Cites:
Cited by: 94
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security